Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionTower Research Capital LLC (TRC)
Latest Disclosed Ownership9,847 shares
Latest Disclosed Value $ 292,555
Tower Research Capital LLC (TRC) reports 2,036.01% increase in ownership of TVTX / Travere Therapeutics, Inc.

On May 15, 2026 - Tower Research Capital LLC (TRC) filed a 13F-HR form disclosing ownership of 9,847 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $292,554 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 461 shares of Travere Therapeutics, Inc.. This represents a change in shares of 2,036.01% during the quarter. The current value of the position is $445,084 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 9,847 9,386 2,036.01 293 1,617.65 0.0050
2026-02-17 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 461 -5,065 -91.66 18 -87.12 0.0004
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 5,526 -19,472 -77.89 132 -64.23 0.0036
2025-08-15 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 24,998 21,474 609.36 370 485.71 0.0100
2025-05-15 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 3,524 -17,843 -83.51 63 -83.06 0.0019
2025-02-13 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 21,367 14,501 211.20 372 287.50 0.0074
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 6,866 -6,951 -50.31 96 -15.04 0.0025
2024-08-13 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 13,817 12,717 1,156.09 114 1,312.50 0.0019
2024-05-15 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 1,100 -4,933 -81.77 8 -85.19 0.0002
2024-02-13 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 6,033 -1,896 -23.91 54 -22.86 0.0007
2023-11-14 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 7,929 1,876 30.99 71 -23.91 0.0022
2023-08-14 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 6,053 2,914 92.83 93 0.0031
2023-05-09 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 3,139 -2,197 -41.17 0 0.0023
2023-02-10 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 5,336 -2,763 -34.12 0 -100.00 0.0046
2022-11-10 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 8,099 -11,762 -59.22 199 -58.63 0.0032
2022-08-15 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 19,861 9,171 85.79 481 74.91 0.0108
2022-05-12 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 10,690 3,389 46.42 275 21.68 0.0026
2022-02-14 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 7,301 1,822 33.25 226 69.92 0.0039
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 5,479 523 10.55 133 84.72 0.0034
2021-08-16 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 4,956 2,606 110.89 72 22.03 0.0019
2021-05-17 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 2,350 799 51.52 59 40.48 0.0010
2021-02-16 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 1,551 -539 -25.79 42 7.69 0.0013
2020-11-16 2020-09-30 13F RETROPHIN COM 761299106 2,090 -3,035 -59.22 39 -62.86 0.0004
2020-08-13 2020-06-30 13F RETROPHIN COM 761299106 5,125 5,125 105 0.0043
2020-02-07 2019-12-31 13F RETROPHIN COM 761299106 0 -1,339 -100.00 0 -100.00
2019-11-05 2019-09-30 13F RETROPHIN COM 761299106 1,339 30 2.29 16 -38.46 0.0011
2019-08-13 2019-06-30 13F RETROPHIN COM 761299106 1,309 1,309 26 0.0018
2018-05-15 2018-03-31 13F RETROPHIN COM 761299106 0 -1,383 -100.00 0 -100.00
2018-02-09 2017-12-31 13F RETROPHIN COM 761299106 1,383 -5,338 -79.42 29 -82.63 0.0037
2017-11-14 2017-09-30 13F RETROPHIN COM 761299106 6,721 6,421 2,140.33 167 2,683.33 0.0138
2017-08-14 2017-06-30 13F RETROPHIN COM 761299106 300 300 6 0.0007
2017-05-19 2017-03-31 13F RETROPHIN COM 761299106 0 -1,426 -100.00 0 -100.00
2017-02-03 2016-12-31 13F RETROPHIN COM 761299106 1,426 487 51.86 27 28.57 0.0029
2016-11-08 2016-09-30 13F RETROPHIN COM 761299106 939 939 0.00 21 0.0021
2016-05-16 2016-03-31 13F RETROPHIN COM 761299106 0 -531 -100.00 0 -100.00
2016-02-10 2015-12-31 13F RETROPHIN COM 761299106 531 -669 -55.75 10 -58.33 0.0016
2015-11-13 2015-09-30 13F RETROPHIN COM 761299106 1,200 -529 -30.60 24 -58.62 0.0023
2015-07-30 2015-06-30 13F RETROPHIN COM 761299106 1,729 -3,814 -68.81 58 -56.39 0.0051
2015-05-12 2015-03-31 13F RETROPHIN COM 761299106 5,543 3,296 146.68 133 375.00 0.0164
2015-02-05 2014-12-31 13F RETROPHIN COM 761299106 2,247 -3,560 -61.31 28 -46.15 0.0084
2014-10-31 2014-09-30 13F RETROPHIN COM 761299106 5,807 621 11.97 52 -52.73 0.0058
2014-05-02 2014-03-31 13F RETROPHIN COM 761299106 5,186 5,186 110 0.0141
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.